Focused Ultrasound Therapy: Improving Patient Care and Lowering Costs

Online Event

Today, healthcare innovation centers on advancing breakthrough treatments to improve patient outcomes. Focused Ultrasound is a revolutionary, noninvasive therapy that can treat multiple diseases and has the potential to address many more with further R&D funding. Join us to learn how, for many patients, this noninvasive, non-pharmacological treatment is a significant improvement over conventional therapies and reduces overall costs. This briefing will educate about the established benefits of focused ultrasound, its potential in other areas of healthcare, and the value of additional research investment to advance this field of medicine.

2022 Black Innovation and Entrepreneurship program, part two: Invest in ideas

Online Event

Are you a current or aspiring inventor or entrepreneur? Would you like to learn from successful innovators and subject matter experts about keys to success? If so, register early for the February 24 Black Innovation and Entrepreneurship program hosted by the United States Patent and Trademark Office (USPTO).

Building Farmer’s Trust: Delivery of Ag Biologicals

Online Event

Brought to you by 3Bar Biologics, hear from the experts why the delivery of Ag Biologicals is important to building farmer’s trust, and what we can do to improve compatibility with different inputs and equipment. Panelists include Moderator, Jane Fife, CTO at 3Bar Biologics • Jim Lappin, Director of SIMPAS Product Portfolio and Alliances at AMVAC • David Flack, Vice President, Business Development at New Leaf Symbiotics • Adam Kayser, Technical Agronomist for the Central and Southern US at Novozymes • Dan Poston, Director of Agronomy at Pivot Bio.

Nationwide Children’s Hospital 2022 Technology Showcase

Online Event

Learn about impactful innovations as well as new startup companies generated from Abigail Wexner Research Institute at Nationwide Children’s Hospital. Join us for talks highlighting novel interventions from Nationwide Children’s researchers.

Non-Dilutive Funding: Monthly GBG Reporting Service Webinar

Online Event

Every third Friday of the month, G2G hosts this online event to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities, such as grants and BAAs that could accelerate company growth. We will share insights from our research and provide some Q&A during the first half hour. We then take a deeper dive on non-dilutive federal government funding sources and related priorities with consultation during the second half hour for our customers.

Founders Unfiltered: A Conversation with Dr. Dan German, Founder of Orthobrain

Online Event

Join JumpStart on Wednesday, March 23, for the next Founders Unfiltered featuring Dr. Dan German, founder of orthobrain. An award-winning orthodontist, Dr. German is well known throughout the dental world. Now he’s helping dentists seamlessly integrate orthodontics into their practice by providing education and real-time support through orthobrain’s innovative platform. Tune in to find out how Dr. German set out to resolve the unmet demand for orthodontics and hear more about how he went from dental practitioner to tech founder.

Virtual Medtech Happy Hour: Securing Non-Dilutive Funding Through SBIR/STTR Grants

Online Event

This event is presented by Project Medtech. Grab your favorite drink (or just a drink), come learn and interact with industry experts while they discuss hot topics in Medtech. Dr. Ashley Mooneyham is President and Director of Grants at Superior Medical Experts, a medical writing and research support company. As Director of Grants, she has helped small businesses in the healthcare innovation space secure over $14 million in non-dilutive seed funding through the SBIR/STTR grant program. Superior Medical Experts provides comprehensive grant assistance that spans company registrations, grant strategy consulting, full research and compliance drafting, and submission in as little as 12 weeks.

Clinical Challenges Under the EU MDR

Online Event

With the EU Medical Device Regulation (MDR) now fully applicable, manufacturers are facing the challenges of both transitioning legacy devices to the MDR, and introducing new products. Although the Medical Device Coordination Group (MDCG) guidance has been forthcoming, there remain significant gaps in guidance and interpretation of requirements, and varying interpretations of expectations. In addition with the limited number of Notified Bodies designated under the MDR, there is substantial pressure to make MDR submissions as soon as possible to avoid the “cliff edge” of May 2024. NAMSA invites you to join this upcoming webinar as our team of regulatory experts discuss practical insights to address these challenges.

Humanizing Healthcare: Elevating Health Experiences

Online Event

The surge in digital healthcare technologies has reshaped the healthcare experience for consumers. Consumers are looking for more personalized health experiences where they are in control of their health but they are also more aware of the risks and benefits of sharing their data. Now more than ever, it’s important organizations understand how to use technology to deliver value while addressing consumer concerns around data, consent and security.

The Need for Transitional Coverage for Emerging Technologies (TCET)

Online Event

For patients on Medicare, the majority of whom are over age 65, time matters. However, newly published research from the Stanford Byers Center for Biodesign shows that patients can wait up to 5 years after FDA authorization to access new medical technologies. Instead, a well-designed transitional coverage program could greatly accelerate patients’ access to care, while reducing the overall cost burden on our healthcare system. This program would also encourage innovation in areas of critically important unmet clinical needs. The Duke-Margolis Center for Health Policy has recommended the addition of several key elements to a transitional coverage pathway, highlighting the need for early engagement between stakeholders to inform and guide evidence development and appropriate use of novel technologies. Please join us to explore these findings and hear the perspectives of physicians, innovators and CMS stakeholders on this important initiative to advance patient care.